JPMorgan Chase & Co’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,317
| Closed | -$13K | – | 6561 |
|
|
2024
Q2 | $13K | Sell |
2,317
-56,314
| -96% | -$315K | ﹤0.01% | 5210 |
|
|
2024
Q1 | $307K | Sell |
58,631
-2,936
| -5% | -$15.4K | ﹤0.01% | 4223 |
|
|
2023
Q4 | $322K | Sell |
61,567
-1,577
| -2% | -$8.25K | ﹤0.01% | 4140 |
|
|
2023
Q3 | $996K | Sell |
63,144
-55,064
| -47% | -$868K | ﹤0.01% | 3401 |
|
|
2023
Q2 | $2.3M | Sell |
118,208
-11,855
| -9% | -$230K | ﹤0.01% | 2960 |
|
|
2023
Q1 | $3.69M | Buy |
130,063
+18,648
| +17% | +$529K | ﹤0.01% | 2636 |
|
|
2022
Q4 | $3.26M | Sell |
111,415
-120,391
| -52% | -$3.52M | ﹤0.01% | 2658 |
|
|
2022
Q3 | $6.13M | Buy |
231,806
+26,959
| +13% | +$712K | ﹤0.01% | 2198 |
|
|
2022
Q2 | $9.1M | Sell |
204,847
-33,892
| -14% | -$1.51M | ﹤0.01% | 1961 |
|
|
2022
Q1 | $11.8M | Sell |
238,739
-5,007
| -2% | -$248K | ﹤0.01% | 1901 |
|
|
2021
Q4 | $12.4M | Sell |
243,746
-87,552
| -26% | -$4.46M | ﹤0.01% | 1935 |
|
|
2021
Q3 | $18.5M | Sell |
331,298
-14,177
| -4% | -$791K | ﹤0.01% | 1614 |
|
|
2021
Q2 | $14.8M | Buy |
345,475
+276,753
| +403% | +$11.8M | ﹤0.01% | 1839 |
|
|
2021
Q1 | $2.87M | Sell |
68,722
-6,813
| -9% | -$284K | ﹤0.01% | 3008 |
|
|
2020
Q4 | $3.52M | Buy |
75,535
+12,662
| +20% | +$590K | ﹤0.01% | 2636 |
|
|
2020
Q3 | $2.63M | Sell |
62,873
-1,618
| -3% | -$67.8K | ﹤0.01% | 2607 |
|
|
2020
Q2 | $3.09M | Sell |
64,491
-3,903
| -6% | -$187K | ﹤0.01% | 2453 |
|
|
2020
Q1 | $3.15M | Sell |
68,394
-7,875
| -10% | -$362K | ﹤0.01% | 2308 |
|
|
2019
Q4 | $4.58M | Sell |
76,269
-3,733
| -5% | -$224K | ﹤0.01% | 2227 |
|
|
2019
Q3 | $4.53M | Sell |
80,002
-18,686
| -19% | -$1.06M | ﹤0.01% | 2248 |
|
|
2019
Q2 | $5.43M | Sell |
98,688
-6,211
| -6% | -$342K | ﹤0.01% | 2072 |
|
|
2019
Q1 | $5.3M | Buy |
104,899
+45,821
| +78% | +$2.31M | ﹤0.01% | 2069 |
|
|
2018
Q4 | $2.38M | Sell |
59,078
-4,426
| -7% | -$178K | ﹤0.01% | 2547 |
|
|
2018
Q3 | $4.4M | Buy |
63,504
+29,215
| +85% | +$2.03M | ﹤0.01% | 2316 |
|
|
2018
Q2 | $2.6M | Buy |
34,289
+31,929
| +1,353% | +$2.42M | ﹤0.01% | 2646 |
|
|
2018
Q1 | $124K | Sell |
2,360
-14
| -0.6% | -$736 | ﹤0.01% | 3868 |
|
|
2017
Q4 | $127K | Buy |
2,374
+1,915
| +417% | +$102K | ﹤0.01% | 3818 |
|
|
2017
Q3 | $27K | Buy |
+459
| New | +$27K | ﹤0.01% | 3922 |
|
|
2016
Q3 | – | Sell |
-124
| Closed | -$5K | – | 4288 |
|
|
2016
Q2 | $5K | Buy |
124
+35
| +39% | +$1.41K | ﹤0.01% | 3949 |
|
|
2016
Q1 | $4K | Buy |
89
+79
| +790% | +$3.55K | ﹤0.01% | 3918 |
|
|
2015
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 4013 |
|
|
2015
Q2 | – | Sell |
-6,630
| Closed | -$278K | – | 3540 |
|
|
2015
Q1 | $278K | Buy |
+6,630
| New | +$278K | ﹤0.01% | 3254 |
|
|
2014
Q2 | – | Sell |
-177,650
| Closed | -$2.27M | – | 3531 |
|
|
2014
Q1 | $2.27M | Buy |
+177,650
| New | +$2.27M | ﹤0.01% | 2439 |
|